ATE266654T1 - Verfahren zur herstellung von als protease inhibitoren wervollen 4-hydroxy-2-oxo-pyran- derivaten - Google Patents

Verfahren zur herstellung von als protease inhibitoren wervollen 4-hydroxy-2-oxo-pyran- derivaten

Info

Publication number
ATE266654T1
ATE266654T1 AT98945806T AT98945806T ATE266654T1 AT E266654 T1 ATE266654 T1 AT E266654T1 AT 98945806 T AT98945806 T AT 98945806T AT 98945806 T AT98945806 T AT 98945806T AT E266654 T1 ATE266654 T1 AT E266654T1
Authority
AT
Austria
Prior art keywords
oxo
hydroxy
producing
protease inhibitors
derivatives used
Prior art date
Application number
AT98945806T
Other languages
English (en)
Inventor
James R Gage
Robert C Kelly
Bradley D Hewitt
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE266654T1 publication Critical patent/ATE266654T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98945806T 1997-09-11 1998-09-03 Verfahren zur herstellung von als protease inhibitoren wervollen 4-hydroxy-2-oxo-pyran- derivaten ATE266654T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5861897P 1997-09-11 1997-09-11
PCT/US1998/017993 WO1999012919A1 (en) 1997-09-11 1998-09-03 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors

Publications (1)

Publication Number Publication Date
ATE266654T1 true ATE266654T1 (de) 2004-05-15

Family

ID=22017924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945806T ATE266654T1 (de) 1997-09-11 1998-09-03 Verfahren zur herstellung von als protease inhibitoren wervollen 4-hydroxy-2-oxo-pyran- derivaten

Country Status (21)

Country Link
US (2) US6077963A (de)
EP (1) EP1015441B1 (de)
JP (3) JP4462760B2 (de)
KR (1) KR100569771B1 (de)
CN (3) CN100471832C (de)
AT (1) ATE266654T1 (de)
CA (1) CA2300204C (de)
CZ (1) CZ298847B6 (de)
DE (1) DE69823844T2 (de)
DK (1) DK1015441T3 (de)
ES (1) ES2221199T3 (de)
FI (1) FI120973B (de)
HK (3) HK1030418A1 (de)
HU (1) HU228986B1 (de)
NO (1) NO321835B1 (de)
NZ (1) NZ503338A (de)
PL (1) PL193240B1 (de)
PT (1) PT1015441E (de)
RU (2) RU2223958C2 (de)
SK (1) SK284974B6 (de)
WO (1) WO1999012919A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60000660T2 (de) * 1999-03-18 2003-06-26 Upjohn Co Verbesserte verfahren fur assymmetrische hydrogenation
US6552204B1 (en) * 2000-02-04 2003-04-22 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
CN1301244C (zh) 2002-02-07 2007-02-21 住友化学工业株式会社 生产(r)－3－羟基－3－(2－苯基乙基)己酸及其中间体的方法
DE10313118A1 (de) 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese
US7512945B2 (en) * 2003-12-29 2009-03-31 Intel Corporation Method and apparatus for scheduling the processing of commands for execution by cryptographic algorithm cores in a programmable network processor
CN100448836C (zh) * 2005-06-03 2009-01-07 浙江中贝化工有限公司 一种抗艾滋病药物关键中间体的制备方法
KR101064459B1 (ko) * 2005-08-24 2011-09-16 화이자 인코포레이티드 Ｈｃｖ 폴리머라제 억제제의 제조 방법
KR101614103B1 (ko) * 2007-11-30 2016-04-21 가부시키가이샤 한도오따이 에네루기 켄큐쇼 발광 소자, 발광 장치 및 전자기기
US8853393B2 (en) * 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1355667A (fr) * 1963-02-05 1964-03-20 Meci Materiel Elect Contr Gaine tubulaire pour électrode servant à la mesure du ph
FR1355668A (fr) * 1963-02-05 1964-03-20 Moteur rotatif à combustion interne perfectionné
FR2096877B1 (de) * 1970-07-09 1973-08-10 Hexachimie
JPH0665657B2 (ja) * 1984-11-08 1994-08-24 日本化薬株式会社 光学活性マンデル酸の製法
JPH072677B2 (ja) * 1988-02-19 1995-01-18 株式会社クラレ （±）―２―ヒドロキシ―４―フェニルブタン酸の光学分割法
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
JP3084577B2 (ja) * 1991-09-27 2000-09-04 山川薬品工業株式会社 光学活性なアトロラクチン酸の製造方法および製造の中間体
JP3178086B2 (ja) * 1992-06-17 2001-06-18 山川薬品工業株式会社 光学活性α−メチルベンジルアミンの製造方法
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
HUT77668A (hu) * 1993-11-19 1998-07-28 Parke, Davis & Company Vírusellenes hatású 5,6-dihidropiron-származékok és hatóanyagként azokat tartalmazó gyógyszerkészítmények
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
CA2300204C (en) 2006-12-12
NO20001274D0 (no) 2000-03-10
FI120973B (fi) 2010-05-31
RU2263106C2 (ru) 2005-10-27
PL193240B1 (pl) 2007-01-31
HK1104027A1 (en) 2008-01-04
EP1015441B1 (de) 2004-05-12
HU228986B1 (en) 2013-07-29
CN1990452A (zh) 2007-07-04
FI20000553A (fi) 2000-03-10
WO1999012919A1 (en) 1999-03-18
PT1015441E (pt) 2004-08-31
KR100569771B1 (ko) 2006-04-11
JP2001515895A (ja) 2001-09-25
CN1298714C (zh) 2007-02-07
HK1063776A1 (en) 2005-01-14
JP5016621B2 (ja) 2012-09-05
NO321835B1 (no) 2006-07-10
PL339138A1 (en) 2000-12-04
NZ503338A (en) 2002-03-01
AU9296598A (en) 1999-03-29
KR20010023864A (ko) 2001-03-26
US6077963A (en) 2000-06-20
US6265604B1 (en) 2001-07-24
CN1284763C (zh) 2006-11-15
JP5266194B2 (ja) 2013-08-21
AU743496B2 (en) 2002-01-24
ES2221199T3 (es) 2004-12-16
CN1268947A (zh) 2000-10-04
DE69823844T2 (de) 2005-04-14
CA2300204A1 (en) 1999-03-18
CN100471832C (zh) 2009-03-25
CZ298847B6 (cs) 2008-02-27
SK2262000A3 (en) 2000-10-09
SK284974B6 (sk) 2006-03-02
RU2223958C2 (ru) 2004-02-20
NO20001274L (no) 2000-05-10
HUP0003593A2 (hu) 2001-02-28
DK1015441T3 (da) 2004-07-26
JP4462760B2 (ja) 2010-05-12
CZ2000804A3 (cs) 2000-08-16
JP2010090157A (ja) 2010-04-22
DE69823844D1 (de) 2004-06-17
JP2009138002A (ja) 2009-06-25
HUP0003593A3 (en) 2002-12-28
RU2003131081A (ru) 2005-04-10
EP1015441A1 (de) 2000-07-05
CN1511820A (zh) 2004-07-14
HK1030418A1 (en) 2001-05-04

Similar Documents

Publication Publication Date Title
HK1104027A1 (en) Compounds useful to produce a protease inhibitor
DE69725354D1 (de) Intermediate zur Herstellung von Thrombininhibitoren als Anticoagulantien
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
ATE342278T1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE69129115D1 (de) Neues verfahren zur behandlung von depression
DE60330146D1 (de) Verfahren zur reinigung von fibrinogen
DE60210298D1 (de) Verfahren zur herstellung von polynucleotivarianten
ATE245192T1 (de) Verfahren zur herstellung von gereinigten papillomavirus proteinen
DE69824839D1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren
DE69829066D1 (de) Verfahren zur reinigung von alkanolaminen
DE60034207D1 (de) Verfahren zur Beseitigung von Abgasen
DE69911430D1 (de) Verfahren zur herstellung von 1-(1h)-benzoquinolizin-3-on derivaten
ATE242772T1 (de) Verfahren zur herstellung von hiv-protease inhibitoren
ATE200805T1 (de) Verfahren zur reduktion von schwefel- und küpenfarbstoffen
ATE291569T1 (de) Verfahren zur herstellung von dnda
DE59108583D1 (de) Verfahren zur reaktivierung von denaturiertem protein
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
ATE181916T1 (de) Verfahren zur herstellung von hiv protease inhibitor ausgehend von (2s)-4-picolyl-2- piperazin-t-butylcarboxamid
ATE186717T1 (de) Verfahren zur herstellung von (e)-2-fluormethylen-4-(4-fluorphenyl)butan-1-ol
DE69203358T2 (de) Verfahren zur Reinigung von Abgas.
DE50112690D1 (de) Verfahren zur aufbereitung von pyrrolidon- und n-vinylpyrrolidon-rückständen
ATE370103T1 (de) Verfahren zur behandlung von schlamm
DE69306744D1 (de) Verfahren zur Herstellung von 2-aryl-5-trifluoro-methyl Pyrrole-Verbindungen
DE59407666D1 (de) VERFAHREN ZUR HERSTELLUNG VON 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDAN
DE59508148D1 (de) Verfahren zur herstellung von wässrigen esterquat-dispersionen durch quaternierung in gegenwart von dispergatorgemischen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1015441

Country of ref document: EP